News
23h
MoneyWeek on MSNFat profits: should you invest in weight-loss drugs?Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
Danish drugmaker Novo Nordisk (NOV: N) has announced that it is expanding patient access to Wegovy (semaglutide ... All the ...
A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The medication - and similar drugs - have been catapulted into the heart of pop ...
Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...
19h
The Healthy @Reader's Digest on MSNA Highly Popular Weight Loss Drug Has Been Recalled in 3 StatesJust today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results